Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus Vogelmeier,Gerard J. Criner,Fernando J. Martinez,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Rongchang Chen,Marc Decramer,Leonardo M. Fabbri,Peter Frith,David M.G. Halpin,M. Victorina López Varela,Masaharu Nishimura,Nicolas Roche,Roberto Rodriguez-Roisin,Don D. Sin,Dave Singh,Robert Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Alvar Agusti +21 more
TLDR
The assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation, and the concept of de‐escalation of therapy is introduced in the treatment assessment scheme.Abstract:
This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.read more
Citations
More filters
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh,Alvar Agusti,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Gerard J. Criner,Peter Frith,David M.G. Halpin,MeiLan K. Han,M. Victorina López Varela,Fernando J. Martinez,Maria Montes de Oca,Alberto Papi,Ian D. Pavord,Nicolas Roche,Don D. Sin,Robert A. Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Claus Vogelmeier +20 more
TL;DR: Blood eosinophils are recommended as a biomarker to support clinical decisions regarding the use of inhaled corticosteroids in chronic obstructive pulmonary disease patients, based on recent evidence from clinical trials.
Journal ArticleDOI
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
TL;DR: The advantages of various drug delivery vehicles are discussed for better understanding of their utility in terms of current medical needs and the application of a wide range of nanomedicines is also described in the context of major chronic diseases.
Journal ArticleDOI
COPD Guidelines: A Review of the 2018 GOLD Report.
TL;DR: The salient features of the GOLD 2018 document are reviewed and commentary on features that merit further discussion are provided based on clinical experience and practice as well as literature review current as of February 2018.
Journal ArticleDOI
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
Liwen Fang,Pei Gao,H L Bao,Xun Tang,Baohua Wang,Yajing Feng,S Cong,Juan Juan,J Fan,Ke Lu,Ning Wang,Yonghua Hu,Linhong Wang +12 more
TL;DR: The estimated overall prevalence of COPD in China in 2014–15 was 13·6%, indicating that this disease has become a major public-health problem.
References
More filters
Journal ArticleDOI
Physician perceptions and management of COPD
Steven Kesten,Kenneth R. Chapman +1 more
TL;DR: Primary care practitioners have a low index of suspicion for obstructive airway disease, markedly underutilized spirometry as a screening tool, consider beta 2-agonists first-line therapy for COPD and asthma, and despite considering COPDand asthma different disease processes, choose similar medications for each disorder.
Journal ArticleDOI
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
TL;DR: Once-daily LABAs used both alone and in combination with long-acting muscarinic antagonists represent a promising advance in the treatment of COPD, and are likely to further improve outcomes for patients.
Journal ArticleDOI
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data
Joan B. Soriano,Bernd Lamprecht,Ana Sofia Ramírez,Pablo Martínez-Camblor,Bernhard Kaiser,Inmaculada Alfageme,Pere Almagro,Ciro Casanova,Cristóbal Esteban,Juan José Soler-Cataluña,Juan P. de-Torres,Marc Miravitlles,Bartolome R. Celli,Jose M. Marin,Milo A. Puhan,Patricia Sobradillo,Peter Lange,Alice L. Sternberg,Judith Garcia-Aymerich,Alice M Turner,MeiLan K. Han,Arnulf Langhammer,Linda Leivseth,Per Bakke,Ane Johannessen,Nicolas Roche,Don D. Sin,Don D. Sin +27 more
TL;DR: Neither GOLD COPD classification schemes have sufficient discriminatory power to be used clinically for risk classification at the individual level to predict total mortality for 3 years of follow-up and onwards, and the prognostic accuracy of the staging documents for mortality is compared.
Journal ArticleDOI
Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
Courtney Crim,Mark T. Dransfield,Jean Bourbeau,Paul W. Jones,Nicola A. Hanania,Donald A. Mahler,Jørgen Vestbo,Jørgen Vestbo,Andrew Wachtel,Fernando J. Martinez,Frank Barnhart,Sally Lettis,Peter M.A. Calverley +12 more
TL;DR: Radiographically confirmed pneumonia risk is increased with inhaled FF/VI, although at less than investigator-defined rates, and modifiable pneumonia risk factors should be considered when attempting to optimize COPD management.
Journal ArticleDOI
Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort
Jessica Bon,Carl R. Fuhrman,Joel L. Weissfeld,Steven R. Duncan,Robert A. Branch,Chung-Chou H. Chang,Yingze Zhang,Joseph K. Leader,David Gur,Susan L. Greenspan,Frank C. Sciurba +10 more
TL;DR: Radiographic emphysema is a strong, independent predictor of low BMD in current and former smokers, and suggests a common mechanistic link between empysema and osteopenia/osteoporosis.
Related Papers (5)
Standardisation of spirometry
Martin R. Miller,John L. Hankinson,Vito Brusasco,Felip Burgos,Richard Casaburi,Allan L. Coates,Robert O. Crapo,Paul L. Enright,C.P.M. van der Grinten,P. Gustafsson,R. Jensen,D.C. Johnson,Neil R. MacIntyre,Roy T. McKay,Daniel Navajas,O. F. Pedersen,Riccardo Pellegrino,Giovanni Viegi,J. Wanger +18 more
An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation
Martijn A. Spruit,Sally J Singh,Chris Garvey,Richard ZuWallack,Linda Nici,Anne E Holland,Suzanne C. Lareau,Fabio Pitta,Louise Sewell,Jo Raskin,Jean Bourbeau,Rebecca Crouch,Frits M.E. Franssen,Richard Casaburi,Jan H. Vercoulen,Ioannis Vogiatzis,Rik Gosselink,Enrico Clini,Tanja Effing,Job van der Palen,Thierry Troosters,Daisy J.A. Janssen,Eileen G. Collins,Judith Garcia-Aymerich,Dina Brooks,Bonnie Fahy,Milo A. Puhan,Martine Hoogendoorn,Rachel Garrod,Annemie M. W. J. Schols,Brian W. Carlin,Roberto P. Benzo,Mike Morgan,Andrew L. Ries,Roger S. Goldstein,Claire A. Dowson,Jan Brozek,Claudio F. Donner,Emiel F.M. Wouters +38 more